Cargando…

Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?

Multiple sclerosis (MS) more than any other neurological disorder has experienced a tremendous progress in available evidence-based innovator disease modifying therapies (DMT). These medications include injectable complex nonbiological drugs (CNBD), the injectable biological products β-interferons-1...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rivera, Victor M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858917/ https://www.ncbi.nlm.nih.gov/pubmed/31313222 http://dx.doi.org/10.1007/s40120-019-0145-0

Ejemplares similares

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
por: Craner, Matthew, et al.
Publicado: (2022)

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
por: Steinberg, Judith, et al.
Publicado: (2019)

Biosimilars: a regulatory perspective from America
por: Kay, Jonathan
Publicado: (2011)

Unmet Needs in Pediatric Functional Constipation
por: Sood, Manu, et al.
Publicado: (2018)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases
por: Schulze-Koops, Hendrik
Publicado: (2017)

Access to care - an unmet need in headache management?
por: Tassorelli, Cristina, et al.
Publicado: (2014)

The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications
por: Bunnik, Eline M., et al.
Publicado: (2017)

Towards a New Understanding of Unmet Medical Need
por: Zhang, Kyann, et al.
Publicado: (2021)

EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018)

Meeting the unmet needs of disabled adults with cerebral palsy
por: Werner, Shirli
Publicado: (2022)

Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines
por: Rivera, Victor M.
Publicado: (2018)

Biosimilar Drugs: What Would Be a Reasonable Extrapolation?
por: Gifoni, Markus A.C., et al.
Publicado: (2017)

Contraceptive preferences and unmet need for contraception in midlife women: where are the data?
por: Harlow, Siobán D., et al.
Publicado: (2017)

What do multiple sclerosis patients and their caregivers perceive as unmet needs?
por: Lorefice, Lorena, et al.
Publicado: (2013)

Fertility preferences and unmet need for family planning in women with multiple sclerosis
por: López-Reyes, Lorena, et al.
Publicado: (2022)

Incorporating Method Dissatisfaction into Unmet Need for Contraception: Implications for Measurement and Impact
por: Rothschild, Claire W., et al.
Publicado: (2021)

Unmet Needs for Geriatric Medicine and Care of the Elderly Physicians Work Force in Canada
por: Madden, Kenneth, et al.
Publicado: (2021)

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
por: Sidiropoulos, Prodromos, et al.
Publicado: (2019)

Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan
por: Murakami, Takaaki, et al.
Publicado: (2021)

Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States
por: Conte, William L., et al.
Publicado: (2023)

Integrating Lawyers Into Perinatal Care Teams to Address Unmet, Health-Harming Legal Needs
por: Patchen, Loral, et al.
Publicado: (2023)

Personalizing Medicine and Technologies to Address the Experiences and Needs of People with Multiple Sclerosis
por: Henschke, Adam, et al.
Publicado: (2021)

The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
por: Kimura, Kimitoshi, et al.
Publicado: (2018)

Effective influenza vaccines for children: A critical unmet medical need and a public health priority
por: Banzhoff, Angelika, et al.
Publicado: (2012)

Regulatory considerations in oncologic biosimilar drug development
por: Macdonald, Judith C, et al.
Publicado: (2015)

Neurofilament light in blood – What more is needed for clinical implementation in multiple sclerosis?
por: Zetterberg, Henrik
Publicado: (2020)

Biosimilar and interchangeable: Inseparable scientific concepts?
por: de Mora, Fernando, et al.
Publicado: (2019)

Interchangeability of Biosimilars: Overcoming the Final Hurdles
por: Barbier, Liese, et al.
Publicado: (2021)

Commentary: Biosimilars in the treatment of retinopathy of prematurity
por: Soni, Tanvi, et al.
Publicado: (2023)

Assessing unmet medical need in India: A regulatory riddle?
por: Bhatt, Arun
Publicado: (2015)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
por: Breccia, Massimo
Publicado: (2022)

Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Unmet Needs of People with Severe Multiple Sclerosis and Their Carers: Qualitative Findings for a Home-Based Intervention
por: Borreani, Claudia, et al.
Publicado: (2014)

Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
por: Capasso, Nicola, et al.
Publicado: (2023)

Psychometric Properties of LUN-MS: A New Questionnaire to Identify the Unmet Needs of People With Multiple Sclerosis
por: Mohamed Abu Baker, Amin, et al.
Publicado: (2023)

Biomedical and Market Issues Surrounding the Advent of Biosimilars
por: Cline, Abigail, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8vtpceqqdp6juci4m4lq93r7fs